Life sciences news
-
IBA and SCK CEN launch Pantera, a joint-venture to produce actinium-225
Thursday September 22nd 2022
Read more
-
New three-year BIMZELX®▼ (bimekizumab) data reinforce long-term maintenance of complete skin clearance in moderate to severe plaque psoriasis
Wednesday September 7th 2022
Read more
-
Biocartis initiates commercialization in Europe of SkylineDx’s innovative Merlin™ Assay (CE-IVD) for melanoma patients
Thursday September 1st 2022
Read more
-
argenx announces European Commission approval of VYVGART™ (efgartigimod alfa-fcab) for the treatment of generalized myasthenia gravis
Thursday August 11th 2022
Read more
-
ANeuroTech receives positive feedback from the FDA for its pivotal Phase IIIb development programme for ANT-01 as an adjunctive anti-depression drug for Major Depressive Disorder
Tuesday July 5th 2022
Read more
-
New agreement paves way for development of first African-owned COVID-19 vaccine
Tuesday June 21st 2022
Read more
-
argenx announces the UK MHRA has granted early access to efgartigimod for generalized myasthenia gravis
Tuesday May 31st 2022
Read more
-
miDiagnostics launches its CE-IVD certified ultra-fast COVID-19 PCR test
Monday May 2nd 2022
Read more
-
Become a flanders.bio member
Your news here?
-
Sequana Medical announces the completion of alfapump implantations in POSEIDON, the North American pivotal alfapump study
Tuesday April 5th 2022
Read more
-
Jyseleca® approved in Japan for ulcerative colitis
Monday March 28th 2022
Read more
-
The fight against cancer intensified thanks to SCK CEN and the IRE
Monday February 28th 2022
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
